- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有139家主力机构披露2025-06-30报告期持股数据，持仓量总计13.59亿股，占流通A股53.98%
- 波段诊断：
-
技术面诊股
诊断结果：4.4技术面打败了9%的股票
技术面评分前10的股票
近期的平均成本为3.49元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为3.49元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"3.49","date":1767518745,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。
[{"date":"2026.01.05","stock":false,"trade":"3.09","ind":"1.38"},{"date":"2025.12.31","stock":"-1.15","trade":"-0.07","ind":"0.09"},{"date":"2025.12.30","stock":"0.00","trade":"-0.48","ind":"-0.00"},{"date":"2025.12.29","stock":"-1.41","trade":"-1.13","ind":"0.04"},{"date":"2025.12.26","stock":"-0.56","trade":"-0.41","ind":"0.10"},{"date":"2025.12.25","stock":"0.56","trade":"0.35","ind":"0.47"},{"date":"2025.12.24","stock":"0.00","trade":"0.28","ind":"0.53"},{"date":"2025.12.23","stock":"-1.12","trade":"-0.30","ind":"0.07"},{"date":"2025.12.22","stock":"-0.28","trade":"0.14","ind":"0.69"},{"date":"2025.12.19","stock":"1.13","trade":"1.80","ind":"0.36"},{"date":"2025.12.18","stock":"0.00","trade":"0.51","ind":"0.16"},{"date":"2025.12.17","stock":"0.85","trade":"0.69","ind":"1.19"},{"date":"2025.12.16","stock":"-0.85","trade":"-2.00","ind":"-1.11"},{"date":"2025.12.15","stock":"-0.56","trade":"-1.10","ind":"-0.55"},{"date":"2025.12.12","stock":"-0.28","trade":"-0.50","ind":"0.41"},{"date":"2025.12.11","stock":"-2.19","trade":"-0.87","ind":"-0.70"},{"date":"2025.12.10","stock":"0.55","trade":"-0.07","ind":"-0.23"},{"date":"2025.12.09","stock":"-1.89","trade":"-1.51","ind":"-0.37"},{"date":"2025.12.08","stock":"-1.07","trade":"0.25","ind":"0.54"},{"date":"2025.12.05","stock":"0.81","trade":"0.10","ind":"0.70"},{"date":"2025.12.04","stock":"0.00","trade":"-0.40","ind":"-0.06"}]
哈药股份,上证指数,化学制药指数
压力支撑
该股压力位为3.47元，支撑位为3.44元。
[{"text":"\u538b\u529b\u4f4d","value":"3.47","date":1767542400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"3.44","date":1767542400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.8资金面打败了4%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体无进出。
更新时间：01月05日 20:38
| 机构今日流向(万元) | 4078.22 | 机构5日流向(万元) | -774.03 |
| 机构10日流向(万元) | -242.16 | 机构20日流向(万元) | -8231.18 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少13231.96万股，其中基金净减仓8家，主力净减仓22家，请投资者中长期谨慎为宜。
截止2025-06-30，共139家主力机构（基金134家，一般法人5家），持仓量总计135949.23万股，占流通A股53.98%
其中，基金持仓与2024-12-31相比：
增仓：28家 ，增持 782.70万股
减仓：36家 ，减持 4296.81万股
新出现在主力名单中：68家 ，持有3065.89万股
从主力名单中消失：90家 ，原持有8623.23万股
其中，基金持仓与2024-12-31相比：
增仓：28家 ，增持 782.70万股
减仓：36家 ，减持 4296.81万股
新出现在主力名单中：68家 ，持有3065.89万股
从主力名单中消失：90家 ，原持有8623.23万股
消息面诊股
诊断结果：5.5消息面打败了64%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 哈药股份：12月31日获融资买入711.77万元
2026-01-01 - 哈药股份：12月30日获融资买入1023.33万元
2025-12-31 - 哈药股份：12月29日获融资买入874.82万元
2025-12-30 - 哈药股份：12月26日获融资买入850.08万元
2025-12-27 - 哈药股份：12月25日获融资买入778.06万元
2025-12-26 - 哈药股份：12月24日获融资买入772.03万元
2025-12-25 - 哈药股份：12月23日获融资买入996.39万元
2025-12-24 - 哈药股份：公司所属企业与欧盟国家存在销售业务，相关
2025-12-23 - 哈药股份：12月22日获融资买入823.94万元
2025-12-23 - 三精制药的“美妆快车”能否驶出药企跨界的长期困局？
2025-12-20
消息列表
| 一般消息 | 高管变动 | 委员会更名 | 2025-12-24 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-10-15 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-15 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-11 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-09-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-04 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-23 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-23 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-26 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.3行业面打败了78%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.01.05","price":"1.38","value":"-0.48"},{"date":"2025.12.31","price":"0.09","value":"-1.13"},{"date":"2025.12.30","price":"-0.00","value":"-0.41"},{"date":"2025.12.29","price":"0.04","value":"0.35"},{"date":"2025.12.26","price":"0.10","value":"0.28"},{"date":"2025.12.25","price":"0.47","value":"-0.30"},{"date":"2025.12.24","price":"0.53","value":"0.14"},{"date":"2025.12.23","price":"0.07","value":"1.80"},{"date":"2025.12.22","price":"0.69","value":"0.51"},{"date":"2025.12.19","price":"0.36","value":"0.69"},{"date":"2025.12.18","price":"0.16","value":"-2.00"},{"date":"2025.12.17","price":"1.19","value":"-1.10"},{"date":"2025.12.16","price":"-1.11","value":"-0.50"},{"date":"2025.12.15","price":"-0.55","value":"-0.87"},{"date":"2025.12.12","price":"0.41","value":"-0.07"},{"date":"2025.12.11","price":"-0.70","value":"-1.51"},{"date":"2025.12.10","price":"-0.23","value":"0.25"},{"date":"2025.12.09","price":"-0.37","value":"0.10"},{"date":"2025.12.08","price":"0.54","value":"-0.40"},{"date":"2025.12.05","price":"0.70","value":"-0.45"},{"date":"2025.12.04","price":"-0.06","value":"-1.08"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 宏源药业 | 40.85% | 20.25% | 5.4分 |
| 2 | 多瑞医药 | 21.08% | 13.33% | 5.7分 |
| 3 | 新诺威 | 20.88% | -5.33% | 5.5分 |
| 4 | 亚虹医药 | 17.69% | 4.54% | 6.0分 |
| 5 | 苑东生物 | 14.79% | 6.21% | 6.5分 |
| 6 | 北陆药业 | 11.40% | 10.99% | 6.5分 |
| 8 | 艾力斯 | 10.33% | -0.90% | 6.6分 |
| 10 | 富祥药业 | 8.91% | 4.58% | 6.1分 |
| 12 | 泰恩康 | 6.97% | 0.98% | 4.9分 |
| 14 | 舒泰神 | 5.85% | 4.01% | 5.8分 |
| 16 | 康芝药业 | 5.45% | -9.15% | 5.9分 |
| 18 | 海创药业 | 4.06% | -4.25% | 4.5分 |
| 20 | 广生堂 | 4.04% | 4.33% | 5.4分 |
| 22 | 亚太药业 | 3.59% | -0.40% | 5.5分 |
| 24 | 莱美药业 | 3.33% | 0.38% | 5.6分 |
| 26 | 贝达药业 | 3.21% | 2.17% | 5.8分 |
| 28 | 奥翔药业 | 2.16% | 3.66% | 5.7分 |
| 30 | 上海谊众 | 1.60% | 0.45% | 5.9分 |
| 32 | 国邦医药 | 1.27% | 6.57% | 6.4分 |
| 34 | 益方生物 | 0.93% | -8.90% | 4.6分 |
| 36 | 奥赛康 | 0.59% | 2.76% | 5.7分 |
| 38 | 千红制药 | 0.49% | 2.13% | 5.6分 |
| 40 | - | 0.35% | 0.29% | 分 |
| 42 | 海普瑞 | 0.08% | 0.75% | 5.8分 |
| 44 | ST诺泰 | -0.05% | -3.36% | 4.7分 |
| 46 | 恩华药业 | -0.20% | -3.90% | 5.3分 |
| 48 | 华特达因 | -0.33% | 0.36% | 5.3分 |
| 50 | 华纳药厂 | -0.62% | -2.85% | 5.4分 |
| 52 | 川宁生物 | -0.78% | 1.50% | 5.2分 |
| 54 | 浙江医药 | -1.00% | 0.07% | 5.5分 |
| 56 | 德展健康 | -1.01% | -1.75% | 4.6分 |
| 58 | 天宇股份 | -1.28% | 2.28% | 5.8分 |
| 60 | 溢多利 | -1.61% | -0.15% | 5.0分 |
| 62 | 复旦张江 | -1.78% | 0.24% | 5.5分 |
| 64 | 小方制药 | -1.82% | -1.38% | 5.8分 |
| 66 | 永安药业 | -1.98% | 0.72% | 5.4分 |
| 68 | 国药现代 | -2.23% | -0.88% | 5.3分 |
| 70 | 恒瑞医药 | -2.30% | -2.71% | 6.4分 |
| 72 | 百济神州 | -2.40% | -3.35% | 5.6分 |
| 74 | ST天圣 | -3.17% | 0.20% | 4.7分 |
| 76 | - | -3.39% | -1.85% | 分 |
| 78 | 福元医药 | -3.42% | -1.88% | 6.2分 |
| 80 | 诚意药业 | -3.49% | -2.23% | 5.5分 |
| 82 | 立方制药 | -3.77% | -1.96% | 5.8分 |
| 84 | - | -4.00% | -1.97% | 分 |
| 86 | *ST赛隆 | -4.37% | 0.52% | 4.0分 |
| 88 | 威尔药业 | -4.55% | 0.00% | 6.2分 |
| 90 | 赛托生物 | -4.68% | 0.65% | 4.8分 |
| 92 | 本立科技 | -4.77% | 0.05% | 5.3分 |
| 94 | 能特科技 | -4.82% | 0.00% | 5.4分 |
| 96 | 山河药辅 | -4.93% | -0.74% | 4.2分 |
| 98 | - | -5.45% | -3.34% | 分 |
| 100 | 新天地 | -5.53% | -0.84% | 5.1分 |
| 102 | 辰欣药业 | -5.61% | -4.04% | 4.9分 |
| 104 | 健友股份 | -5.74% | -2.80% | 5.3分 |
| 106 | 东诚药业 | -5.98% | 2.19% | 5.6分 |
| 108 | - | -6.07% | -3.57% | 分 |
| 110 | 尔康制药 | -6.32% | 1.14% | 5.6分 |
| 112 | 华东医药 | -6.42% | -0.92% | 4.7分 |
| 114 | 西点药业 | -6.85% | -1.96% | 4.8分 |
| 116 | 东北制药 | -7.02% | -0.93% | 5.5分 |
| 118 | 丰原药业 | -7.12% | -1.08% | 5.4分 |
| 120 | 哈药股份 | -7.26% | -2.54% | 4.6分 |
| 122 | 津药药业 | -7.67% | -2.39% | 5.1分 |
| 124 | 卫信康 | -7.80% | -3.49% | 5.6分 |
| 126 | 通化金马 | -8.50% | -6.14% | 4.8分 |
| 128 | 润都股份 | -8.87% | 1.94% | 4.8分 |
| 130 | 健康元 | -8.91% | -1.28% | 5.1分 |
| 132 | 常山药业 | -9.07% | -4.28% | 4.6分 |
| 134 | 华仁药业 | -9.27% | 0.62% | 4.9分 |
| 136 | 东亚药业 | -10.06% | -2.04% | 4.5分 |
| 138 | 海南海药 | -10.38% | -10.49% | 5.8分 |
| 140 | 百利天恒 | -10.67% | -5.53% | 4.3分 |
| 142 | 金城医药 | -11.24% | 0.56% | 4.7分 |
| 144 | 金石亚药 | -11.34% | -1.03% | 4.5分 |
| 146 | 科伦药业 | -11.50% | -0.98% | 4.5分 |
| 148 | 神奇制药 | -12.79% | -3.04% | 5.4分 |
| 150 | 泽璟制药 | -13.62% | -8.05% | 5.2分 |
| 152 | 北大医药 | -15.03% | 0.47% | 5.1分 |
| 154 | 拓新药业 | -15.56% | -2.95% | 4.1分 |
| 156 | 信立泰 | -18.48% | -12.80% | 4.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 55/217 ， 122/217。
[{"date":"2025-09-30","value":"5.97","vol":"1.51"},{"date":"2025-06-30","value":"4.74","vol":"1.23"},{"date":"2025-03-31","value":"3.90","vol":"-0.14"},{"date":"2024-12-31","value":"12.48","vol":"19.62"},{"date":"2024-09-30","value":"10.23","vol":"4.62"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.97 | 4.74 | 3.90 | 12.48 | 10.23 |
| 行业(%) | 1.51 | 1.23 | -0.14 | 19.62 | 4.62 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"26.02","vol":"49.36"},{"date":"2025-06-30","value":"27.04","vol":"49.33"},{"date":"2025-03-31","value":"26.66","vol":"49.14"},{"date":"2024-12-31","value":"28.24","vol":"50.78"},{"date":"2024-09-30","value":"28.23","vol":"50.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
26.02 | 27.04 | 26.66 | 28.24 | 28.23 |
| 行业(%) | 49.36 | 49.33 | 49.14 | 50.78 | 50.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 72/217 ， 109/217。
[{"date":"2025-09-30","value":"-1.92","vol":"142.98"},{"date":"2025-06-30","value":"-0.21","vol":"79.25"},{"date":"2025-03-31","value":"0.78","vol":"-0.67"},{"date":"2024-12-31","value":"4.65","vol":"18.07"},{"date":"2024-09-30","value":"6.63","vol":"45.94"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-1.92 | -0.21 | 0.78 | 4.65 | 6.63 |
| 行业(%) | 142.98 | 79.25 | -0.67 | 18.07 | 45.94 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-35.35","vol":"-3.26"},{"date":"2025-06-30","value":"-24.37","vol":"58.57"},{"date":"2025-03-31","value":"20.48","vol":"-11.22"},{"date":"2024-12-31","value":"59.10","vol":"-22.02"},{"date":"2024-09-30","value":"74.97","vol":"-34.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-35.35 | -24.37 | 20.48 | 59.10 | 74.97 |
| 行业(%) | -3.26 | 58.57 | -11.22 | -22.02 | -34.66 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 2/217 ， 9/217。
[{"date":"2025-09-30","value":"0.84","vol":"0.31"},{"date":"2025-06-30","value":"0.57","vol":"0.21"},{"date":"2025-03-31","value":"0.29","vol":"0.10"},{"date":"2024-12-31","value":"1.13","vol":"0.43"},{"date":"2024-09-30","value":"0.86","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.84 | 0.57 | 0.29 | 1.13 | 0.86 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"4.48","vol":"1.94"},{"date":"2025-06-30","value":"3.13","vol":"1.30"},{"date":"2025-03-31","value":"1.65","vol":"0.66"},{"date":"2024-12-31","value":"6.08","vol":"3.19"},{"date":"2024-09-30","value":"4.57","vol":"2.12"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
4.48 | 3.13 | 1.65 | 6.08 | 4.57 |
| 行业(次) | 1.94 | 1.30 | 0.66 | 3.19 | 2.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"-4.94","vol":"4.43"},{"date":"2025-06-30","value":"8.19","vol":"2.74"},{"date":"2025-03-31","value":"-11.13","vol":"-26.98"},{"date":"2024-12-31","value":"15.66","vol":"-373.99"},{"date":"2024-09-30","value":"2.55","vol":"-9.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -4.94 | 8.19 | -11.13 | 15.66 | 2.55 |
| 行业 | 4.43 | 2.74 | -26.98 | -373.99 | -9.47 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.29","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.34","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.29 | - | 0.34 | - |
| 行业 | 0.00 | 1.73 | 0.00 | 2.00 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 39/217 ， 11/217。
[{"date":"2025-09-30","value":"1.45","vol":"3.50"},{"date":"2025-06-30","value":"1.44","vol":"3.69"},{"date":"2025-03-31","value":"1.42","vol":"3.61"},{"date":"2024-12-31","value":"1.35","vol":"3.36"},{"date":"2024-09-30","value":"1.35","vol":"3.67"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.45 | 1.44 | 1.42 | 1.35 | 1.35 |
| 行业 | 3.50 | 3.69 | 3.61 | 3.36 | 3.67 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.11","vol":"2.75"},{"date":"2025-06-30","value":"1.13","vol":"2.90"},{"date":"2025-03-31","value":"1.14","vol":"2.83"},{"date":"2024-12-31","value":"1.08","vol":"2.65"},{"date":"2024-09-30","value":"1.07","vol":"2.93"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.11 | 1.13 | 1.14 | 1.08 | 1.07 |
| 行业 | 2.75 | 2.90 | 2.83 | 2.65 | 2.93 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 19/217 ， 18/217。
[{"date":"2025-09-30","value":"54.49","vol":"33.63"},{"date":"2025-06-30","value":"54.71","vol":"33.66"},{"date":"2025-03-31","value":"55.24","vol":"33.90"},{"date":"2024-12-31","value":"58.34","vol":"34.07"},{"date":"2024-09-30","value":"58.30","vol":"32.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
54.49 | 54.71 | 55.24 | 58.34 | 58.30 |
| 行业(%) | 33.63 | 33.66 | 33.90 | 34.07 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.36","vol":"0.94"},{"date":"2025-06-30","value":"1.37","vol":"0.88"},{"date":"2025-03-31","value":"1.40","vol":"1.47"},{"date":"2024-12-31","value":"1.59","vol":"0.84"},{"date":"2024-09-30","value":"1.60","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.36 | 1.37 | 1.40 | 1.59 | 1.60 |
| 行业(%) | 0.94 | 0.88 | 1.47 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"3.71","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.64","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.95","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"6.29","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"6.47","blueLineValue":"0.26","type":"YC"}]